Initiating Treatment for Lower-Risk MDS With Symptomatic Anemia
The panel shares at what point they decide to start treatment for patients with lower-risk MDS and symptomatic anemia.
Stay updated with breaking news from Recent Updates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The panel shares at what point they decide to start treatment for patients with lower-risk MDS and symptomatic anemia.
Yazan Madanat, MD, details the available options for first-line treatment of patients with lower-risk MDS and symptomatic anemia.
If you are an avid user of the popular social media platform Snapchat, you may have been tempted to unsubscribe from the service at one point or another. Unsubscribing from an online service can be a daunting decision, and it’s important to consider the potential consequences of your choice before making the final call. In […]
David Harpole, MD, discusses study design, results and clinical implications of the AEGEAN study of perioperative immunotherapy (neoadjuvant durvalumab plus chemotherapy followed by adjuvant durvalumab in the treatment of early-stage NSCLC
Rachna Shroff, MD, provides a look at an upcoming program reviewing recent data updates in the treatment of hepatocellular carcinoma.